BAMCO Inc’s Zimmer Biomet ZBH Stock Holding History

BAMCO Inc’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,708	Closed	-$539K	–	364
2019 Q4	$539K	Buy	3,708 +1,133	+44%	+$156K	﹤0.01%	301
2019 Q3	$343K	Buy	+2,575	New	+$333K	﹤0.01%	305

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BAMCO Inc's ZBH Position: Q1 2020 in Review

BAMCO Inc sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 3,708 shares — an estimated $539K sold.

BAMCO Inc first reported a position in ZBH in Q3 2019 and held it in 2 quarters. The position peaked at $539K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

BAMCO Inc reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
BAMCO Inc sold 3,708 Zimmer Biomet shares in Q1 2020, an estimated $539K.
BAMCO Inc first reported a position in Zimmer Biomet in Q3 2019 and held it in 2 quarters.
BAMCO Inc's Zimmer Biomet position peaked at $539K in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on BAMCO Inc's 13F filing for Q1 2020, filed 15 May 2020.